Press Releases

Published January 10, 2013

Press Releases

Filed under: Honolulu Drug Treatment

The presentation will include an overview of Actinium's clinical stage drug candidates Actimab-A and Iomab-B for treatment of hematological cancers and discussion of its proprietary patented alpha particle immunotherapy technology (APIT). Abengoa …
Read more on International Business Times (press release)

Positive Response from European Regulatory Procedure Supports Approval of …

Filed under: Honolulu Drug Treatment

[2],[3] Elvanse is the first of a new class of dopamine modulators approved in Europe that uses pro-drug technology to release the active drug in the body. It is currently available in the USA and Canada under the trade name Vyvanse?, for the treatment …
Read more on MarketWatch (press release)